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Background. Hypophysitis is an inﬂammatory disease of the pituitary gland that may mimic pituitary tumors clinically and
radiologically. Case Description. We report a case of a xanthomatous hypophysitis initially diagnosed as pituitary adenoma. A
31-year-old woman presented with headache, diabetes insipidus, and amenorrhea. A head CT scan showed no intrasellar changes,
while an MRI scan showed a sellar cystic mass. An endocrinological work up revealed mild hypocortisolism and diabetes insipidus
(DI). Transsphenoidal surgery was performed. The intraoperative histological examination suggested a pituitary adenoma. The
removed tissue showed central necrosis surrounded by accumulation of foamy cells and xanthomatous epithelioid cells. The
patient made an uneventful postoperative recovery, Nevertheless, DI persisted and the adenohypophysis hypofunction did not
recover. Conclusion. We describe an unusual inﬂammatory lesion of the pituitary gland mimicking an adenoma. A high level of
clinical suspicion of inﬂammatory disorders is necessary for correct diagnosis and optimal management.
1.Introduction
Inﬂammatory disorder of the pituitary gland (hypophysi-
tis) is a rare but increasingly recognized cause of pitu-
itary dysfunction [1] that should be considered in the
diﬀerential diagnosis of sella turcica lesions [1]. Sec-
ondary hypophysitis is rare, while primary hypophysitis
has traditionally been classiﬁed as lymphocytic (LH), gran-
ulomatous (GH), and xanthomatous hypophysitis (XH)
[1–3].
Xanthomatous hypophysitis (XH) has been recently de-
scribed, and it is the rarest of the three types [1]. XH is
characterized by mixed inﬂammatory cell inﬁltrates con-
sisting of foamy histiocytes, plasma cells, and small round
mature lymphocytes inﬁltrating the anterior pituitary gland
[3–6].
Clinically the lesion may mimic a pituitary neoplasm
as a result of mass eﬀect and hypothalamic-hypophyseal
endocrine dysfunction [6]. We report here the case of a
young woman who presented with a sellar mass on a head
MRI and endocrine dysfunction.
2.CaseReport
A 31-year-old women was admitted to our department with
a one-month history of headache and diabetes insipidus
(DI). At admission, the patient was found to suﬀer from
amenorrhea. Furthermore, the patient had a positive history
for ulcerative colitis under medical treatment.
At the ﬁrst physical examination, the patient appeared in
good general conditions, had no fever, no hypertension, no
signs of meningism, and no neurological deﬁcits. The ﬁrst
pituitary function work up showed gonadotropic hormons
in the lower normal range (NR): cortisol levels: at 08a.m.
= 12.1ug/dl (NR = 8.0–25.0.), at 02p.m. = 3.6ug/dl
(NR = 1.0–17), at 10p.m. = 1.6ug/dl (NR = 1.0–5.0);
PRL = 13.8ng/mL(NR = 3.0–27.0); FSH = 1.9mUI/mL
(NR = 2.0–13.0 follicular phase); LH = 2.0mUI/mL (NR =
2.0–12.0 follicular phase); progesterone = 0.27ng/mL
(NR = 0.10–1.00 follicular phase); estradiol = 26.4pg/mL
(NR = 20.0–200.0 follicular phase); TSH = 0.24uIU/mL
(NR = 0.25–5.00); FT3 = 2.49pg/mL (NR = 2–4); FT4 =
1.25ng/dl (NR = 0.6–1.7); GH = 1.1ng/mL(NR= 0–4.7).2 Journal of Oncology
A second preoperative endocrinological work up one
month later showed reduced corticol levels, that is, cor-
tisol (08:00a.m.) = 0.9ug/dl; FSH = 7.9mUI/mL; PRL =
10.3ng/mL; LH = 10.1mUI/mL; progesterone = 0.19ng/mL;
estradiol = 7.9pg/mL; FT3 = 2.27pg/mL; FT4 = 1.41ng/dl;
GH = 0.8ng/mL. Inﬂammatory indices such as WBC
and haptoglobin were slightly increased (11.45e3/uL and
282mg/dl,resp.).Plasmaosmolaritywasnormal.Urinetests,
including electrolytes, were within normal limits, except for
low levels of phosphate, BUN, creatinine, and magnesium.
Ac o n t r a s th e a dC Ts c a nw a sd e s c r i b e da sn o r m a l .Aﬁ r s t
head Gadolinium MRI showed an increased volume of the
pituitary gland with mild compression of the optic chiasm.
A second head MRI (multiplanar FSE −/+ Gad, GRE-T2∗)
with thin slices on sellar region revealed a widening of the
sella occupied by a solid lesion with necrotic core and a
hemorrhagic spot. The lesion was measured to be 21 × 20 ×
12mm. It extended into the suprasellar cistern determining
a minimal displacement of the optic chiasm (Figure 1).
Indication for transsphenoidal surgery was given. Prior
to surgery the patient underwent a complete pituitary
function work-up (see above). An ophtalmological work-
up revealed no visual ﬁelds abnormalities. A preoperative
thyroid gland echography showed increased volume with
small nonechogenic nodules. An abdomen CT scan showed
intestinal parietal thickening and pseudopolypoid nodular
disease compatible with ulcerative images.
Endovenous intranasal Desmopressin (DDAVP-Minirin)
was started few days after the admission, and prophylactic
Hydrocortisone was given 48 hours prior to surgery.
Surgical exploration via the endoscopic transsphenoidal
route revealed a cystic lesion containing pus-like ﬂuid,
which was drained after dural opening (Figure 2(a)). Tissue
samples were taken for histological examination from the
cyst wall. The intraoperative histopathological examination
indicated a pituitary adenoma (Figure 2(b)).
The postoperative full histopathological work-up re-
vealed an inﬂammatory inﬁltrate of numerous foamy his-
tiocytes, multinucleated giant cells containing cholesterol
clefts, and lymphocytes inﬁltrating between residual nests
of normal pituicytes (Figure 3). On immunohistochemical
sections, the inﬁltrating foamy cells, were strongly positive
for CD68, a macrophage marker (Figure 4). There was no
evidence of associated adenomas, granulomas, Langherans’
cells or neutrophilic exudates. No haemosiderin was seen.
The rupture of a Rathke’s cleft cyst was excluded by the
pathologist as no cylindric ciliated epithelium could be seen.
There were no surgical complications. The patient suf-
fered from transient rhinoliquorrea. Pituitary function did
not improve; 5 days after surgery she underwent a com-
plete endocrinological work-up with the following ﬁndings:
cortisol at 08a.m. = 14.5ug/dl, at 12a.m. = 11.9, and at
12p.m. = 12.4; PRL = 1.6ng/dl; FSH = 6.1mUI/mL; LH =
3.0mUI/mL; TSH = 0.21uUI/ml, FT3 = 1.69pg/mL, FT4 =
1.5ng/dl; GH = 0.3ng/mL, ACTH = 5.9pg/mL (NR = 5–77);
IGF1 = 53ng/mL (NR = 115–500); C-peptide = 2.2ug/mL
(NR = 0.8–3.0). The patient continued to take DDAVP,
and she was started on cortone acetate 25 mg 1/2cp ×
3/die. Postoperative electrolytes were always within a normal
(a)
(b)
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Figure 1: Pre-operative axial (a), coronal (b) and sagittal (c) Gado-
linium-enhanced T1-w MR images showing the cystic lesion in the
sella.
range. Urine output required one daily administration of
vasopressin (nasal spray). Hormonal substitution therapy
after discharge was prescribed. The headache resolved after
surgery.
The patient underwent an endocrinological work-up at
1, 3, and 8 months after surgery; serum prolactin gradually
increased from 5.25 to 8.9ng/mL. Cortisol level increased
from 0.9ug/dl preoperativly to 18ug/dl at 3 months and
31ug/dl at 8 months postoperatively. Urinary cortisol lev-
els also increased. FSH, LH, and TSH remained in the
lower normal range while FT3 and FT4 slightly increased.Journal of Oncology 3
(a)
(b)
Figure 2: (a) Intraoperative image showing the pus-like ﬂuid
drained at dural opening. (b) Intraoperative frozen section showing
round and polygonal cells, with a diﬀuse growth pattern; no
evidence of inﬂammatory cells or foamy histiocytes.
GH = 0.4ng/mL at one month postoperatively. PCR was 3.19
at the follow-up. Elecrolytes were within normal range. A
postoperative Gadolinium-enhanced head MRI at 8 months
showed a normal pituitary gland with no pathological
changes (Figure 5).
Eight months postoperatively, the patient still required
glucocorticoid and estrogen replacement therapy as amen-
horrea still persisted. Cortone acetate has been progressively
reduced 12 months after surgery with cortisol levels remain-
ing within normal range. Recently, the patient decided
to stop estroprogestinic drugs because of a pregnancy
desire; amenhorrea was still present. She must also continue
DDAVP.
3. Discussion
Hypophystis is an infrequent inﬂammatory disease of the
pituitary gland that may be misdiagnosed as a pituitary
adenoma or other sellar masses as a Ratcke’s cleft cyst. Histo-
logically hypophysitis includes three distinct histopathologi-
cal subtypes: Lymphocytic Hypophysitis (LH), Granuloma-
tous Hypophysitis (GH), and Xanthomatous Hypophysitis
(XH) [1–3]. Some authors classify the xanthogranulomatous
(XGH) and necrotizing hypophysistis (NH) as autonomous
entities [2, 3]. XGH has been recently deﬁned as a new
category by Tashiro et al. for the presence of multinucleated
(a)
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Figure 3: Hematoxylin-Eosin stain. Fragments of intact, normal
pituitary gland inﬁltrated by foamy histiocytes.
Figure 4: Postoperative immunohistochemical stain. Chronic
inﬂammatory cells reaction with collections of foamy histiocytes
(IHC: CD68, fast red).
giant cells [3], and it has also been described in association
with adamantinomatous craniopharyngiomas [4]. In terms
of the site of inﬂammation, hypophysitis is also subdivided
into adenohypophysitis and infundibuloneurohypophysitis
[3]. The latter is thought to be a diﬀerent entity from
LH because inﬂammation is conﬁned to the hypothalamic
neurohypophyseal system causing DI [3, 7, 8]. For this
reason, it is thought to be one of the causes of idiopathic DI
[7, 8]. On MR imaging, a thickening of the neurohypophysis
or pituitary stalk is usually seen [7]. Since in idiopathic
DI a lack of normal early enhancement of the posterior
pituitary is often described, the etiopathogenetic hypothesis4 Journal of Oncology
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Figure 5: Postoperative coronal (a) and sagittal (b) T1-w MR
images, showing no pathological changes in the sellar region.
is focused on the decreased posterior pituitary vascularity
due to congenital lack, to poor development of the posterior
pituitary arterial supply, or to secondary changes of vascular
destruction [8].
LH is the most common type and is characterized by
inﬁltration of the anterior pituitary gland with lymphocytes
and plasma cells and by ﬁbrosis, most commonly observed
in females during or after pregnancy [7, 9]. GH does not
have a high predominance in females and is characterized by
granulomas with epithelioid histiocytes and multinucleated
giant cells; it is diﬀerent from systemic giant-cell disorders
such as tuberculosis, sarcoidosis, or syphilis [7]. Few cases
of GH with giant cell reaction caused by the rupture of a
Rathke’s cleft cyst have been described [10]. NH consists of
inﬂammation with necrosis of the hypothalamus, pituitary
stalk, adenohypophysis, and infundibuloneurohypophysis,
often accompanied by hypofunction and DI [3].
Xanthomatous hypophysitis (XH) is a rare inﬂammatory
disease that usually involves the anterior lobe of the pituitary
gland [1]. Since the ﬁrst report in 1998 by Folkerth et al.
[11] ,af e wc a s e so fX Hh a v eb e e nr e p o r t e di nl i t e r a t u r e[ 3–
6, 12]. Clinical and laboratory ﬁndings suggest an autoim-
mune basis for primary hypophysitis [2, 11]. The patient
presented in this report had a history of ulcerative colitis,
supporting this hypothesis, although autoimmune disorders
are predominantly associated with lymphocytic hypophysitis
[3].
XH has been shown to have a predilection for young
women [4]. Headache is a common complaint at presenta-
tion, while visual disturbances are uncommon [1, 2].
The clinical symptoms of primary hypophysitis are
mainlyduetoinﬂammatoryirritationofsellarandparasellar
structures.
DI, probably caused by inﬂammatory inﬁltration rather
thanbycompressionoftheposteriorlobeandpituitarystalk,
is rare in XH because inﬂammation is predominant in the
anterior pituitary lobe while it occurs in 50% of patients
suﬀeringfromLHandGHandcorrespondstopituitarystalk
thickening in MRI studies [1, 7]. It can be assumed that
in XH a circumscribed anterior pituitary lesion may lead
to compression of the pituitary gland without alteration of
pituitary stalk and optic chiasm [1]. Moreover, DI is not
often seen at the clinical onset of pituitary adenomas (PA).
MR imaging is the procedure of choice in the evaluation of
sellar masses, although diagnosis by MRI alone can only be
suspected: most XH cases appear as an enlargement of the
pituitary gland with hypointense and round cystic lesions
in T1-weighted images [1, 2, 4, 5]. At surgery, thick ﬂuid
material is found within the cystic lesion [6, 12].
Gutenberg et al. (ANJR, 2009) proposed a radiologic
score to distinguish autoimmune hypophysitis from non
secreting PA [13]. In the diﬀerential diagnosis between
hypophysitis and PA, the peculiar radiologic features of
the ﬁrst ones are a symmetric enlargement of pituitary
gland, a homogeneous appearance both on pre- and post-
Gadolinium images, and an intense contrast enhancement.
In contrast, PA are typically asymmetric showing het-
erogeneous enhancement and had a lower Gadolinium
uptake. Moreover, a thickened pituitary stalk is typical
for autoimmune hypophysitis [7, 13, 14]. Others patho-
logical entities to be considered in the diﬀerential diag-
nosis are pituitary abscesses (nowadays uncommon), sec-
ondary hypophysitis and “noninfectious” granulomatous
processes.
XH is characterized histologically by an inﬂammatory
inﬁltrate of foamy histiocytes [3, 4, 6]. The basic structure
of anterior pituitary is generally preserved [2, 6], without
alteration of the pituitary stalk and optic chiasm [2]. Several
biopsies should be performed for an exact histological
diagnosis.
The overall prognosis for XH is good, but improvement
of pituitary function after transsphenoidal surgery has been
reported in less then 50% of the cases in the literature [1, 3].
Chronic inﬂammation may result in destruction and ﬁbrosis
of the pituitary gland [4].
In their initial description of XH, Folkhert et al. [11]
reported two 30-year-old women presenting with menstrual
dysfunction and a 12-year-old girl presenting with nausea,
headache, and symptoms of DI. Subsequently, Deodhare et
al. reported about a 43-year-old female patient presenting
with hyperprolactinemia, GH and cortisol deﬁciency, and
a DI. Cheung et al. and Tashiro et al. reported about three
m o r ec a s e so ff e m a l ep a t i e n t sa ﬀected by XH diagnosed after
a transsphenoidal surgery.Journal of Oncology 5
Burt et al., while reporting two cases of XH in two young
men, have described the ﬁrst documented case of XH with
full recovery of pituitary function after surgery [4].
Gutenberg et al. [1] in a study involving 21 lympho-
cytic, 6 granulomatous, and 4 XH cases have shown that
endocrinological and neuroradiological improvement under
pre- or post-operative high-dose corticosteroids is most
often incomplete and transient. A prospective trial of gluco-
corticoiduseinLHshowedthatmethylprednisolonereduced
MRI mass in seven out of nine patients and improved
anterior pituitary function in four patients. As far as XH
is concerned, they showed no beneﬁt after either pre- or
post-surgical corticosteroids, while 50% of XH cases had an
improvement of anterior pituitary dysfunction shortly after
surgery and none suﬀered from endocrinological deteriora-
tion.OurpaperconﬁrmsthetendencyofXHhypophysitisto
cause a long lasting-though mild-hypopituitarism.
W h i l es t e r o i dt h e r a p ys e e m st ob el e s se ﬀective in XH
compared to other kinds of primary hypophysitis, surgical
exploration is recommended in almost all pseudotumoral
hypophysitis in order to relieve symptoms and secure a
diagnosis [1, 14]. Headache seems to improve in most of
patients who underwent surgery [1].
Al o n g - t e r mf o l l o w - u po nX Hp a t i e n t si sn o ty e t
available. This will be useful to compare the eﬀectiveness of
diﬀerent therapeutic strategies. We suggest that in case of
radiological or serological suspicion of inﬂammatory disease
of the pituitary gland, a conﬁrmatory biopsy through a
transsphenoidal approach should be performed. In case of
compression of sellar and suprasellar structures, surgical
removal should be recommended [12].
Abbreviations
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